Stockreport

Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome

BIO BLAST PHARMA LTD ORDINARY  (ORPN) 
Last bio blast pharma ltd ordinary earnings: 5/26 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bioblastpharma.com/investor-overview-0
PDF Tel Aviv, Israel, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN) (“Bioblast”), a clinical-stage, orphan disease-focused biotechnology company, [Read more]